Impact Biomedical IBO Growth Metrics (2022-2026)

NYSE IBO
$0.46 -0.03 (-7.15%)
As of: Sep 10, 2026 · 3:57 PM EDT
Reported Financials

Impact Biomedical Quarterly Growth Metrics

Periods 16 quarters
Latest Jun 2026

Impact Biomedical reported revenue growth of -57.14% and asset growth of -12.15% for the quarter ended Jun 2026. These growth metrics cover 16 quarters of results from Sep 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y) -4.01%-4.07%3.58%-54.54%-54.80%-56.80%-61.01%-14.22%-14.79%-12.15%
Assets Growth (3y) -27.93%-28.59%
Assets (QoQ) -1.97%-1.00%-0.62%-0.54%5.85%-56.55%-1.18%-4.94%-4.47%-4.41%-1.83%-2.00%
Capital Expenditures (QoQ)Capex (QoQ) 140.00%-91.67%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) -50.00%-33.33%1,227.36%199,800.00%65,800.00%31,100.00%-99.55%-99.85%-98.48%-98.40%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y) 14.47%49.38%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) 6,600.00%-99.50%100.00%0.00%133,300.00%-25.07%-34.07%-52.66%-98.08%-75.00%566.67%-50.00%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y) 0.00%100.36%200.00%0.00%-200.00%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y) 44.22%26.07%37.00%29.70%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ) -27,400.00%98.55%-175.00%90.91%200.00%0.00%-200.00%300.00%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) 16.33%-19.28%52.47%47.48%-49.18%-127.71%-41.49%-80.26%38.76%110.04%31.96%167.72%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y) 8.57%31.48%22.94%38.23%
Cash from Operations (QoQ)Cash from Ops. (QoQ) 54.74%-179.34%27.71%8.46%35.47%-11.32%20.12%-160.00%1.50%30.83%-1.76%11.67%116.15%-568.69%201.29%
EBITDA Margin Growth (1y) -0.70M
EBITDA Margin Growth (3y) -1.49M
EBITDA Margin (QoQ) 1.12M0.93M
EBIT Growth (1y) -34.40%-21.26%-10.37%3.99%37.90%-4.55%-2,202.99%-31.00%-84.19%15.88%-126.63%39.12%
EBIT Growth (3y) -15.41%-2.17%-41.79%11.36%
EBIT Margin Growth (1y) -0.69M
EBIT Margin Growth (3y) -1.50M
EBIT Margin (QoQ) 1.12M0.93M
EBIT (QoQ) -18.53%-16.09%22.19%-25.53%-6.94%-5.66%32.31%18.81%-80.03%-2,227.51%96.15%-14.16%17.78%69.33%
EBT Growth (1y) -40.30%-20.35%75.96%-17.55%21.14%460.32%-2,049.09%-28.06%-1,523.53%-134.78%-78.72%95.12%
EBT Growth (3y) -161.89%-14.68%-39.08%14.53%
EBT Margin Growth (1y) 18.17M
EBT Margin Growth (3y) -20.34M
EBT Margin (QoQ) 19.68M0.93M
EBT (QoQ) -22.40%-436.30%83.81%-32.04%-5.00%-7.14%20.86%11.42%579.75%-739.00%95.28%-1,023.00%89.72%69.35%
EPS (Basic) Growth (1y) -8,180.05%46.43%57.02%-932.23%-468.83%2,339.72%-12,189.90%-10.13%-1,224.56%-132.79%80.00%99.45%
EPS (Basic) Growth (3y) -1,740.90%-57.86%-31.50%25.39%
EPS (Basic) (QoQ) -16,197.13%-55.00%80.46%-67.73%-5.44%-24.36%-369.30%7.57%515.18%-782.40%95.79%-1,011.70%89.72%69.36%
FCF Margin Growth (1y) 2.56M
FCF Margin (QoQ) 0.65M2.23M
Free Cash Flow Growth (1y)FCF Growth (1y) 16.21%-19.28%52.70%48.32%-48.96%-127.71%-41.49%-80.26%38.76%110.04%31.96%167.72%
Free Cash Flow Growth (3y)FCF Growth (3y) 8.57%31.48%23.07%38.05%
Free Cash Flow (QoQ)FCF (QoQ) 54.74%-180.72%26.89%9.80%35.57%-11.32%20.12%-160.00%1.50%30.83%-1.76%11.67%116.15%-568.69%201.29%
Gross Margin Growth (1y) -0.00M
Gross Margin (QoQ) 873.00
Gross Profit Growth (1y) -66.67%
Gross Profit (QoQ) 183.33%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y) -61.05%-9.37%12.59%57.84%72.40%65.04%-966.20%-11.18%-84.89%2.08%-816.68%-136.27%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y) 6.33%27.92%-62.58%-6.44%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ) -79.09%-7.88%23.73%-9.30%-21.62%13.78%63.21%28.45%-54.06%-2,529.22%96.16%-18.99%18.41%69.33%
Net Cash Flow Growth (1y)NCF Growth (1y) 760.00%-102.02%200.00%-150.00%1,246.46%-234.50%-68,200.00%-69,300.00%-122.96%114.95%102.50%168.01%
Net Cash Flow Growth (3y)NCF Growth (3y) -173.24%44.39%166.84%517.97%
Net Cash Flow (QoQ)NCF (QoQ) -230.00%98.99%300.00%9,800.00%-201.01%100.50%-200.00%266,700.00%-125.09%-1.79%-1.91%11.82%116.34%-83.00%2,676.47%
Net Income Growth (1y) -40.30%47.36%62.54%-17.55%21.14%460.32%-2,049.09%-28.06%-1,523.53%-134.78%-78.72%95.12%
Net Income Growth (3y) -161.89%12.95%-39.08%14.53%
Net Income (QoQ) -179.85%-50.54%74.78%-32.04%-5.00%-7.14%20.86%11.42%579.75%-739.00%95.28%-1,023.00%89.72%69.35%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) -50.55%46.43%63.27%-46.42%19.33%465.49%-2,094.33%-32.85%-1,514.40%-134.73%-78.72%95.12%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y) -169.65%12.06%-51.49%14.04%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) -196.31%-55.00%80.46%-67.73%-5.44%-6.28%22.11%7.59%577.73%-738.10%95.28%-1,023.00%89.72%69.35%
Net Margin Growth (1y) 18.17M
Net Margin Growth (3y) -20.36M
Net Margin (QoQ) 19.68M0.93M
Operating Income Growth (1y)Op. Inc Growth (1y) -34.40%-21.26%-10.37%3.99%37.90%-4.55%-2,202.99%-31.00%-84.19%15.88%-126.63%39.12%
Operating Income Growth (3y)Op. Inc Growth (3y) -15.41%-2.17%-41.79%11.36%
Operating Income (QoQ)Op. Inc (QoQ) -18.53%-16.09%22.19%-25.53%-6.94%-5.66%32.31%18.81%-80.03%-2,227.51%96.15%-14.16%17.78%69.33%
Operating Margin Growth (1y) -0.69M
Operating Margin Growth (3y) -1.50M
Operating Margin (QoQ) 1.12M0.93M
Profit After Tax Growth (1y)PAT Growth (1y) -40.30%47.36%62.54%-17.55%20.70%460.83%-2,054.64%-28.06%-1,514.40%-134.73%-78.95%95.12%
Profit After Tax Growth (3y)PAT Growth (3y) -161.89%12.95%-39.14%14.53%
Profit After Tax (QoQ)PAT (QoQ) -179.85%-50.54%74.78%-32.04%-5.00%-7.14%20.86%10.92%577.73%-739.75%95.30%-1,023.00%89.72%69.39%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) 3.99%-2.07%-2.42%-94.08%-94.39%-95.07%-95.39%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) -0.34%-0.69%-0.70%-0.35%-0.70%-93.97%-5.88%-12.50%-7.14%
Return on Assets [ROA] Growth (1y)ROA Growth (1y) 0.00M-0.01M-0.01M-0.02M-0.02M0.00M0.01M
Return on Assets [ROA] (QoQ)ROA (QoQ) 448.00-42.0048.000.00M-0.01M-0.01M-0.01M-0.00M122.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) 351.00-0.01M-0.03M0.08M0.06M0.02M-0.09M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) -91.00-34.0089.00388.00-0.01M-0.02M0.11M-0.02M47.00
Return on Sales [ROS] Growth (1y)ROS Growth (1y) -0.69M
Return on Sales [ROS] Growth (3y)ROS Growth (3y) -1.50M
Return on Sales [ROS] (QoQ)ROS (QoQ) 1.12M0.93M
Revenue Growth (1y) -57.14%
Revenue Growth (3y) -48.08%
Revenue (QoQ) 157.14%-57.14%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y) 4,865.52%
Share-based Compensation (QoQ)Stock Comp. (QoQ) 52.63%-93.10%
Tax Rate (QoQ) 0.02M
Total Debt Growth (1y) 141.70%14.45%-32.06%-13.24%42.97%232.32%471.60%
Total Debt (QoQ) 0.26%104.92%-47.05%5.20%-40.48%161.70%-12.74%144.52%2.37%